Abstract
Naïve CD8 T cells have the potential to differentiate into a spectrum of functional states during an immune response. How these developmental decisions are made and what mechanisms exist to suppress differentiation toward alternative fates remains unclear. We employed in vivo CRISPR-Cas9–based perturbation sequencing to assess the role of ~40 transcription factors (TFs) and epigenetic modulators in T cell fate decisions. Unexpectedly, we found that knockout of the TF Klf2 resulted in aberrant differentiation to exhausted-like CD8 T cells during acute infection. KLF2 was required to suppress the exhaustion-promoting TF TOX and to enable the TF TBET to drive effector differentiation. KLF2 was also necessary to maintain a polyfunctional tumor-specific progenitor state. Thus, KLF2 provides effector CD8 T cell lineage fidelity and suppresses the exhaustion program.
Original language | English (US) |
---|---|
Article number | eadn2337 |
Journal | Science |
Volume | 387 |
Issue number | 6735 |
DOIs | |
State | Published - Feb 14 2025 |
Funding
We thank Joshi lab members for helpful discussions and reviewing the manuscript. We also thank the Yale Flow Cytometry Core, Yale School of Medicine Comparative Pathology Research Core, and the Yale Center for Genome Analysis. Graphical figures, including the print summary figure, were created with Biorender.com. We thank the Wherry lab for providing an initial stock of LCMV Clone13. We thank S. Karimeddiny and S. Lanahan for useful discussion and input. We thank the entire Joshi lab for thoughtful discussion and feedback related to this study. The Yale Flow Cytometry Core is supported in part by NIH grant P30CA016359 and S10OD026996. This work was supported by T32 AI155387(EF), R01CA237037-01A1, grants from the Lung Cancer Research Foundation, and the Pershing Square Sohn Foundation. N.S.J. was supported by Mark Foundation Emerging Leader Award. G.G.F. was supported by Immunohematology/Transfusion Medicine Research Training Award, T32, NHLBI, NIH. B.G.H. was supported by T32AR007016. J.S.T. was supported by Chan Zuckerberg Biohub Investigator Award and NIH (R01AI170116).
ASJC Scopus subject areas
- General